Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have ...

A newly identified inflammatory signaling target may help weaken the protective environment surrounding pancreatic tumors and ...

Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...

KS Hegde Hospital, Mangaluru performs 9-hour robotic Whipple surgery on pancreatic cancer patient after chemo; minimal blood ...

Pancreatic cancer begins in the pancreas, which is located behind the stomach. It is often difficult to detect early because symptoms typically appear only after the cancer has spread. As a result, it ...

In a randomized trial of patients with left-sided resectable pancreatic cancer, minimally invasive pancreatectomy showed comparable overall survival and disease-free survival to open surgery, ...

Surgery has the potential to cure pancreatic cancer if all the cancer can be removed. Patients of Fred Hutch Cancer Center have surgery for pancreatic cancer at UW Medical Center – Montlake by expert ...

Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it. The field is split between clinicians who view preoperative treatment as the ...

Patients who have been treated for pancreatic cancer could benefit from a newly developed blood test that could identify tiny ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with obesity who underwent bariatric surgery had ...

Stage 2 pancreatic cancer includes stages 2A and 2B. Stage 2A is when the cancer tumor has grown to over 4 centimeters (cm). Stage 2B is when it has spread from the pancreas to up to three nearby ...

A four-marker blood panel that includes two newly identified proteins detected stage I and II pancreatic cancer with 87.5 percent sensitivity at a 5 percent false-positive rate, according to findings ...